Elysium Health
Elysium Health is a Consumer Longevity company founded in 2014 and based in New York, United States. It has raised $71.2M in total funding, most recently a Venture.
Founded in 2014 by CEO Eric Marcotulli, Dan Alminana, and MIT aging biologist Leonard 'Lenny' Guarente, Elysium Health translates academic research on cellular aging into consumer supplements developed with input from leading scientists. Its flagship product, Basis, combines nicotinamide riboside and pterostilbene to raise and sustain NAD+ levels and launched in 2015. In March 2025 the company introduced COFACTOR, a collagen system pairing collagen-production support with an NAD+ boost. Elysium has raised roughly $71 million from investors including General Catalyst.
One of the earliest science-forward NAD+ supplement brands, anchored by an MIT aging researcher and a focus on published clinical data.
elysiumhealth.com ↗·Consumer Longevity·
United States·private 
